# Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)

> **NCT00622115** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 72 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT00622115
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2011-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00622115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00622115, "Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00622115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*